GEISINGER MEDICAL CENTER
1. Target Overview & Investment Thesis
GEISINGER MEDICAL CENTER is a 525-bed large academic medical center in MONTOUR, PA with $1.58B in net patient revenue and a 4.1% operating margin. The hospital serves a payer mix of 23.1% Medicare, 2.9% Medicaid, and 74.0% commercial.
Thesis: Undervalued. Our ML models identify $116.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.1% to 11.5% (+736bps).
| Net Revenue HCRIS | $1.58B |
| Current EBITDA COMPUTED | $65.4M |
| Operating Margin COMPUTED | 4.1% |
| Occupancy HCRIS | 83.9% |
| Revenue / Bed COMPUTED | $3.0M |
| Net-to-Gross HCRIS | 14.1% |
| Distress Probability ML | 37.0% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 4.1% places it above the state median. Among 35 size-comparable peers (262-1050 beds), the median margin is -6.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (262-1050), prioritizing same-state peers. 35 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GEISINGER MEDICAL CENTER (Target) | PA | 525 | $1.58B | 4.1% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| THE CHILDRENS HOSPITAL OF PHIL | PA | 667 | $2.70B | -26.8% |
| MILTON S. HERSHEY MEDICAL CENT | PA | 616 | $2.08B | -2.8% |
| TEMPLE UNIVERSITY HOSPITAL | PA | 761 | $1.99B | 0.8% |
| THOMAS JEFFERSON UNIV. HOSPITA | PA | 868 | $1.93B | -23.1% |
| YORK HOSPITAL | PA | 533 | $1.47B | 9.7% |
| LANCASTER GENERAL HOSPITAL | PA | 620 | $1.33B | -2.6% |
| UPMC PINNACLE HOSPITALS | PA | 561 | $1.29B | 8.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $116.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $33.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $31.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $31.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $19.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.0M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $65.4M |
| + RCM Uplift | +$116.5M |
| Pro Forma EBITDA | $181.9M |
| Current Margin | 4.1% |
| Pro Forma Margin | 11.5% |
| WC Released (1x) | $60.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $100.6M | $1.60B | 15.87x | 73.8% |
| Base (11x exit) | 10.0x | 11.0x | $100.6M | $1.79B | 17.78x | 77.8% |
| Bull Case | 9.0x | 11.0x | $90.6M | $2.21B | 24.36x | 89.4% |
| Bull (12x exit) | 9.0x | 12.0x | $90.6M | $2.43B | 26.87x | 93.1% |
| Bear Case | 11.0x | 10.0x | $110.7M | $981.2M | 8.87x | 54.7% |
| Bear (11x exit) | 11.0x | 11.0x | $110.7M | $1.12B | 10.08x | 58.7% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 35 hospitals with 262-1050 beds
- Same-state prioritization (n=36)
- Comp margins: P25=-19.2% / P50=-6.4% / P75=0.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.